Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03298035 · ClinicalTrials.gov registry record · NA

A Comparison of Non-invasive Ventilation Methods Used to Prevent Endotracheal Intubation Due to Apnea in Very Low Birth Weight Infants

A NA study of Apnea of Prematurity, sponsored by The University of Texas Health Science Center, Houston.

Completed
Registry status
NA
Development phase
19
Enrollment target
1
Study location

NCT03298035: Completed NA study of Apnea of Prematurity, sponsored by The University of Texas Health Science Center, Houston.

NCT03298035 is a NA study of Apnea of Prematurity that has completed, run by The University of Texas Health Science Center, Houston. The registered enrollment target is 19 participants, below the 406-participant average among 6 other Apnea of Prematurity trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03298035, a NA study of Apnea of Prematurity, has completed, sponsored by The University of Texas Health Science Center, Houston.

COMPLETED
Registry status
NA
Development phase
19 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to determine whether nasal intermittent positive pressure ventilation (NIPPV) reduces the need for endotracheal intubation in very low birth weight infants with persistent apnea who fail nasal continuous positive airway pressure (NCPAP).

Conditions Studied

Interventions

  • DEVICE NCPAP as mode for apnea prevention
  • DEVICE NIPPV as rescue mode for apnea prevention

Study Locations (1)

Texas

  • The University of Texas Health Science Center at Houston - Houston

Trial Details

FieldValue
Enrollment Target 19 participants
Start Date 2017-11-11
Est. Completion 2018-12-31
Phase NA

What the finished NCT03298035 record still lists

NCT03298035 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 19 participants, a relatively small participant target, below the 406-participant average among 6 other Apnea of Prematurity trials with a reported enrollment target (95% lower).

The record links to 1 condition, with Apnea of Prematurity appearing as the primary indexed condition, and to 2 interventions - of which NCPAP as mode for apnea prevention is the first listed.

NCT03298035 reports a single indexed study location in Texas.

Frequently Asked Questions

What is clinical trial NCT03298035 about?

NCT03298035 is a clinical study titled "A Comparison of Non-invasive Ventilation Methods Used to Prevent Endotracheal Intubation Due to Apnea in Very Low Birth Weight Infants". The purpose of this study is to determine whether nasal intermittent positive pressure ventilation (NIPPV) reduces the need for endotracheal intubation in very low birth weight infants with persistent apnea who fail nasal continuous positive airway pressure (NCPAP).

What is the current status of trial NCT03298035?

This trial is currently completed. It is a NA study. The enrollment target is 19 participants. The study started on 2017-11-11. Estimated completion is 2018-12-31.

What conditions does trial NCT03298035 study?

This clinical trial studies the following conditions: Apnea of Prematurity.

What interventions are being tested in trial NCT03298035?

The interventions under investigation include: NCPAP as mode for apnea prevention (DEVICE), NIPPV as rescue mode for apnea prevention (DEVICE).

Who is sponsoring clinical trial NCT03298035?

This trial is sponsored by The University of Texas Health Science Center, Houston, which has 732 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03298035 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Apnea of Prematurity

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03207464 · 19 participants · Phase 1

    Molecular Imaging of NET Using [C-11]MRB-PET in MS

  • NCT04318717 · 19 participants · Phase 2

    Pembrolizumab and Hypofractionated Radiation Therapy for the Treatment of Mucosal Melanoma

  • NCT05103904 · 19 participants · Phase 2

    Lenvatinib for the Treatment of Recurrent Hepatocellular Carcinoma After Liver Transplant

  • NCT05607407 · 19 participants · Phase 2

    Methimazole in Patients With Progressive Glioblastoma

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03298035, the US trial registry maintained by the National Library of Medicine. NCT03298035 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.